Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
BBDC
|
Matthew Freund
President |
BUY
Open market or private purchase
|
Direct | 2,500 Added 13.53% |
$24,300
$9.72 p/Share
|
Dec 11
2024 |
|
NXJ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 34,906 Reduced 0.0% |
$440,164
$12.61 p/Share
|
Dec 11
2024 |
|
NMAI
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 28,875 Reduced 0.0% |
$371,043
$12.85 p/Share
|
Dec 11
2024 |
|
MIO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,176 Added 0.0% |
$14,441
$12.28 p/Share
|
Dec 11
2024 |
|
PFS
|
James A. Christy
EVP, CRO of Provident Bank |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 9.27% |
$73,080
$20.88 p/Share
|
Dec 11
2024 |
|
ACCD
|
Robert N Cavanaugh
President |
SELL
Open market or private sale
|
Direct | 214 Reduced 0.1% |
$774
$3.62 p/Share
|
Dec 11
2024 |
|
ACCD
|
Stephen H. Barnes
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 222 Reduced 0.1% |
$803
$3.62 p/Share
|
Dec 11
2024 |
|
ACCD
|
Rajeev Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 667 Reduced 0.08% |
$2,414
$3.62 p/Share
|
Dec 11
2024 |
|
ENCP
|
Swee Guan Hoo
Director |
SELL
Open market or private sale
|
Direct | 70,000 Reduced 4.85% |
$90,300
$1.29 p/Share
|
Dec 11
2024 |
|
ENCP
|
Sukses Engineering Sdn Bhd Suria
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 250,000 Reduced 0.91% |
$382,500
$1.53 p/Share
|
Dec 11
2024 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 3 Added 0.0% |
$3,850
$1283.63 p/Share
|
Dec 11
2024 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Direct | 354 Added 0.79% |
$931
$2.63 p/Share
|
Dec 11
2024 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 804 Added 0.0% |
$2,114
$2.63 p/Share
|
Dec 11
2024 |
|
FET
|
C Christopher Gaut
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.76% |
$30,620
$15.31 p/Share
|
Dec 11
2024 |
|
FET
|
Louis Raspino
Director |
SELL
Open market or private sale
|
Direct | 4,950 Reduced 23.49% |
$76,279
$15.41 p/Share
|
Dec 11
2024 |
|
WSBF
|
Stephen J Schmidt
Director |
SELL
Open market or private sale
|
Direct | 478 Reduced 0.68% |
$7,232
$15.13 p/Share
|
Dec 11
2024 |
|
DLX
|
William C Zint
SVP, Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 120 Added 1.01% |
$2,854
$23.79 p/Share
|
Dec 11
2024 |
|
GRNT
|
Luke C Brandenberg
President and CEO |
BUY
Open market or private purchase
|
Direct | 8,495 Added 7.22% |
$51,819
$6.1 p/Share
|
Dec 11
2024 |
|
TEM
|
Bradley A Keywell
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 395,800 Reduced 0.0% |
$16,952,114
$42.83 p/Share
|
Dec 11
2024 |
|
AUID
|
Thomas Robert Szoke
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 6.05% |
$6,340
$6.34 p/Share
|
Dec 11
2024 |
|
AVDL
|
Thomas S Mchugh
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 5,000 Added 5.52% |
$52,450
$10.49 p/Share
|
Dec 11
2024 |
|
PX
|
210 Capital, LLC |
SELL
Open market or private sale
|
Indirect | 155,000 Reduced 0.0% |
$2,095,600
$13.52 p/Share
|
Dec 11
2024 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 35,921 Reduced 0.0% |
$22,688,781
$631.63 p/Share
|
Dec 11
2024 |
|
DYN
|
Richard William Scalzo
SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct | 1,455 Reduced 1.13% |
$40,914
$28.12 p/Share
|
Dec 11
2024 |
|
DYN
|
Oxana Beskrovnaya
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 2,334 Reduced 1.14% |
$65,632
$28.12 p/Share
|
Dec 11
2024 |
|
OLMA
|
Naseem Zojwalla
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 14,522 Reduced 11.17% |
$131,133
$9.03 p/Share
|
Dec 11
2024 |
|
OLMA
|
David C. Myles
CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct | 13,614 Reduced 2.22% |
$122,934
$9.03 p/Share
|
Dec 11
2024 |
|
OLMA
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct | 8,137 Reduced 1.05% |
$73,477
$9.03 p/Share
|
Dec 11
2024 |
|
OLMA
|
Sean Bohen
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 57,174 Reduced 19.13% |
$516,281
$9.03 p/Share
|
Dec 11
2024 |
|
OLMA
|
Shane William Charles Kovacs
CH. OPERATING & FINANCIAL OFF. |
SELL
Open market or private sale
|
Direct | 18,356 Reduced 3.27% |
$165,754
$9.03 p/Share
|
Dec 11
2024 |
|
FOUR
|
Jordan Frankel |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 2.2% |
$494,400
$98.88 p/Share
|
Dec 11
2024 |
|
RELY
|
Matthew B. Oppenheimer
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 14,583 Reduced 0.33% |
$315,138
$21.61 p/Share
|
Dec 11
2024 |
|
CRCT
|
Arora Ashish
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 21,250 Reduced 0.55% |
$127,500
$6.0 p/Share
|
Dec 11
2024 |
|
APP
|
Arash Adam Foroughi
CEO & Chairperson |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 1.63% |
$16,406,500
$328.13 p/Share
|
Dec 11
2024 |
|
LDI
|
Anthony Li Hsieh
Director |
SELL
Open market or private sale
|
Indirect | 134,563 Reduced 0.0% |
$287,964
$2.14 p/Share
|
Dec 11
2024 |
|
JOF
|
Paige Ouimet |
BUY
Open market or private purchase
|
Direct | 3,111 Added 50.0% |
$24,950
$8.02 p/Share
|
Dec 11
2024 |
|
LBRT
|
Christopher A Wright
Chairman of the Board and CEO |
SELL
Open market or private sale
|
Direct | 5,064 Reduced 0.2% |
$96,924
$19.14 p/Share
|
Dec 11
2024 |
|
ADGI
|
Terrance Mcguire |
SELL
Open market or private sale
|
Indirect | 160,400 Reduced 0.0% |
$94,636
$0.59 p/Share
|
Dec 11
2024 |
|
TCBK
|
Cory W Giese
Director |
SELL
Open market or private sale
|
Direct | 5,100 Reduced 45.42% |
$252,297
$49.47 p/Share
|
Dec 11
2024 |
|
GAM-PB
|
Anang K. Majmudar
Senior Vice-President |
BUY
Open market or private purchase
|
Direct | 400 Added 8.33% |
$20,824
$52.06 p/Share
|
Dec 11
2024 |
|
BRP
|
Elizabeth Krystyn |
SELL
Open market or private sale
|
Indirect | 88,306 Reduced 0.0% |
$3,801,573
$43.05 p/Share
|
Dec 11
2024 |
|
CULP
|
Aron R. English
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,300 Added 0.0% |
$12,029
$5.23 p/Share
|
Dec 11
2024 |
|
OPRT
|
R Neil Williams
Director |
BUY
Open market or private purchase
|
Direct | 25,000 Added 15.12% |
$96,750
$3.87 p/Share
|
Dec 11
2024 |
|
PASG
|
Orbimed Advisors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 80 Reduced 0.0% |
$64
$0.8 p/Share
|
Dec 11
2024 |
|
ROAD
|
Charles E Owens
Director |
SELL
Open market or private sale
|
Indirect | 16,203 Reduced 0.0% |
$1,598,587
$98.66 p/Share
|
Dec 11
2024 |
|
OPK
|
Phillip Md Et Al Frost
CEO & Chairman |
BUY
Open market or private purchase
|
Indirect | 500,000 Added 0.0% |
$780,000
$1.56 p/Share
|
Dec 11
2024 |
|
PB
|
Ned S Holmes |
SELL
Open market or private sale
|
Indirect | 600 Reduced 0.0% |
$49,200
$82.0 p/Share
|
Dec 11
2024 |
|
PB
|
Ned S Holmes |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.45% |
$41,085
$82.17 p/Share
|
Dec 11
2024 |
|
THRM
|
Thomas Stocker
SVP, General Manager, Europe |
SELL
Open market or private sale
|
Direct | 1,295 Reduced 8.8% |
$55,659
$42.98 p/Share
|
Dec 11
2024 |
|
HPQ
|
Alex Cho
President, Personal Systems |
SELL
Open market or private sale
|
Direct | 40,287 Reduced 38.38% |
$1,401,987
$34.8 p/Share
|
Dec 11
2024 |